Novel Approaches for Graft-versus-Host Disease Prevention Compared to Contemporary Controls (BMT CTN 1203)
NCT02208037
Acute Leukemia, Anemia
Duarte, California, United States
View Trial DetailsNCT Number: NCT01483664
The purpose of this study is to improve the communication skills of physicians who transition lymphoma cancer patients from the end of treatment to survivorship.
This study is active but is not currently recruiting participants.
18 year and older
All sexes
Observational
Moffitt Cancer Center, Tampa, Florida, United States
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Physicians:
Patients of Physicians:
For part 1 - have scans indicating remission and completing planned chemotherapy and/or radiation therapy. The treating physician will determine that clinical remission has been achieved based on their best judgment.
For part 2 (longitudinal phase): - have new scans indicating remission and completing planned chemotherapy and/or radiation therapy. The treating physician will determine that clinical remission has been achieved based on their best judgment.
Exclusion criteria
Physicians:
Patients of Physicians:
For Part 2 ONLY (longitudinal phase):
Time frame: 3 years
Time frame: 3 years
use of strategies, tasks and skills about transitioning lymphoma patients from the end of primary treatment to survivorship.
Time frame: 3 years
(MSKCC and MD Anderson baseline data only) The study team will look for qualitative themes to better understand the content of these conversations and the need for survivorship care planning. Half of these recordings were with MSKCC patients and physicians and half were with MD Anderson patients and physicians.
Memorial Sloan Kettering Cancer Center
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02208037
Acute Leukemia, Anemia
Duarte, California, United States
View Trial DetailsNCT01181271
Chronic Disease, Chronic Lymphocytic Leukemia
Boston, Massachusetts, United States
View Trial DetailsNCT00791011
Diffuse Large Cell Lymphoma, Hemic and Lymphatic Diseases
View Trial DetailsNCT00741871
B Cell Lymphoma, Hemic and Lymphatic Diseases
Houston, Texas, United States
View Trial Details